Geode Capital Management
NBP

Geode Capital Management’s NovaBridge Biosciences American Depositary Shares NBP Stock Holding History

Geode Capital Management’s Portfolio NBP Stock Details NBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$134K Hold
68,849
– – ﹤0.01% 4034
2026
Q1 		$169K Buy
68,849
+23,765
+53% +$79.5K ﹤0.01% 3972
2025
Q4 		$179K Sell
45,084
-9,478
-17% -$41.9K ﹤0.01% 3944
2025
Q3 		$206K Hold
54,562
– – ﹤0.01% 3915
2025
Q2 		$132K Buy
54,562
+32,525
+148% +$44.1K ﹤0.01% 3992
2025
Q1 		$18.2K Hold
22,037
– – ﹤0.01% 4369
2024
Q4 		$18.7K Hold
22,037
– – ﹤0.01% 4392
2024
Q3 		$27.3K Sell
22,037
-12,310
-36% -$15.4K ﹤0.01% 4362
2024
Q2 		$57.4K Hold
34,347
– – ﹤0.01% 4258
2024
Q1 		$63.9K Hold
34,347
– – ﹤0.01% 4266
2023
Q4 		$65.3K Hold
34,347
– – ﹤0.01% 4285
2023
Q3 		$45.3K Sell
34,347
-213
-0.6% -$468 ﹤0.01% 4441
2023
Q2 		$103K Sell
34,560
-208
-0.6% -$668 ﹤0.01% 4319
2023
Q1 		$120K Sell
34,768
-18,997
-35% -$92K ﹤0.01% 4271
2022
Q4 		$224K Buy
53,765
+23,855
+80% +$90.3K ﹤0.01% 4038
2022
Q3 		$119K Sell
29,910
-13,595
-31% -$103K ﹤0.01% 4492
2022
Q2 		$491K Sell
43,505
-137,809
-76% -$1.65M ﹤0.01% 3773
2022
Q1 		$2.93M Buy
181,314
+6,017
+3% +$154K ﹤0.01% 3062
2021
Q4 		$8.25M Buy
175,297
+18,197
+12% +$1.09M ﹤0.01% 2582
2021
Q3 		$11.3M Buy
157,100
+18,009
+13% +$1.3M ﹤0.01% 2372
2021
Q2 		$11.6M Buy
139,091
+128,599
+1,226% +$8.48M ﹤0.01% 2355
2021
Q1 		$508K Hold
10,492
– – ﹤0.01% 3802
2020
Q4 		$494K Buy
10,492
+5,154
+97% +$203K ﹤0.01% 3592
2020
Q3 		$251K Buy
+5,338
New +$176K ﹤0.01% 3643

Other funds holding NBP

HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
ACM
AIHC Capital Management Central $104M AUM
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $22.2B AUM 58.34% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Geode Capital Management's NBP Position: Q2 2026 in Review

Geode Capital Management held its NovaBridge Biosciences American Depositary Shares (NBP) position steady in Q2 2026 at 68,849 shares worth $134K. The position accounts for ﹤0.01% of the portfolio, ranked #4034.

Geode Capital Management first reported a position in NBP in Q3 2020 and has held it in 24 quarters since. The position peaked at $11.6M in Q2 2021. 49 funds tracked by Wall St. Rank hold NBP as of Q2 2026.

  • Geode Capital Management held 68,849 shares of NovaBridge Biosciences American Depositary Shares worth $134K as of Q2 2026.
  • Geode Capital Management left its NovaBridge Biosciences American Depositary Shares share count unchanged in Q2 2026.
  • NovaBridge Biosciences American Depositary Shares made up ﹤0.01% of Geode Capital Management's portfolio in Q2 2026, its #4034 holding.
  • Geode Capital Management first reported a position in NovaBridge Biosciences American Depositary Shares in Q3 2020 and has held it in 24 quarters since.
  • Geode Capital Management's NovaBridge Biosciences American Depositary Shares position peaked at $11.6M in Q2 2021.
  • 49 funds tracked by Wall St. Rank held NovaBridge Biosciences American Depositary Shares as of Q2 2026.

Based on Geode Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.